Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Fierce Pharma
BMS touts commercial execution, reckons with clinical setbacks
Four failed phase 3 trials of BMS' growth products "collectively have relatively limited impact on the long-term growth of the company," the CEO said.
Angus Liu
Jul 31, 2025 11:10am
BMS hands 5 autoimmune drugs to Bain-backed spinout
Jul 29, 2025 5:08am
BMS names AZ's Cristian Massacesi as new chief medical officer
Jul 25, 2025 9:26am
BMS-backed Dispatch unveils with $216M, Carl June as cofounder
Jul 23, 2025 6:30am
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
Biopharma layoffs hit 4-year monthly high in May
Jul 8, 2025 2:26pm
